COVID-19 complicated by parainfluenza co-infection in a patient with chronic lymphocytic leukemia

Eur J Haematol. 2020 Oct;105(4):508-511. doi: 10.1111/ejh.13475. Epub 2020 Jul 10.

Abstract

The number of people suffering from the new coronavirus SARS-CoV-2 continues to rise. In SARS-CoV-2, superinfection with bacteria or fungi seems to be associated with increased mortality. The role of co-infections with respiratory viral pathogens has not yet been clarified. Here, we report the course of COVID-19 in a CLL patient with secondary immunodeficiency and viral co-infection with parainfluenza.

Keywords: COVID-19; chronic lymphocytic leukemia; immunodeficiency.

Publication types

  • Case Reports

MeSH terms

  • Antibodies, Viral / blood
  • COVID-19 / complications*
  • COVID-19 / immunology
  • COVID-19 / therapy
  • Coinfection / complications*
  • Humans
  • IgG Deficiency / complications
  • IgG Deficiency / immunology
  • IgG Deficiency / therapy
  • Immunoglobulins, Intravenous / therapeutic use
  • Leukemia, Lymphocytic, Chronic, B-Cell / complications*
  • Leukemia, Lymphocytic, Chronic, B-Cell / immunology
  • Leukemia, Lymphocytic, Chronic, B-Cell / therapy
  • Male
  • Middle Aged
  • Pandemics
  • Paramyxoviridae Infections / complications*
  • SARS-CoV-2 / immunology
  • Spike Glycoprotein, Coronavirus / immunology

Substances

  • Antibodies, Viral
  • Immunoglobulins, Intravenous
  • Spike Glycoprotein, Coronavirus
  • spike protein, SARS-CoV-2